Larkspur Health Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LSPRU and buy or sell other stocks, ETFs, and their options commission-free!About LSPRU
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases.
CEOStephen C. Glover
CEOStephen C. Glover
Employees7
Employees7
HeadquartersWeston, Florida
HeadquartersWeston, Florida
Founded2014
Founded2014
Employees7
Employees7
LSPRU Key Statistics
Market cap168.40M
Market cap168.40M
Price-Earnings ratio-102.61
Price-Earnings ratio-102.61
Dividend yield—
Dividend yield—
Average volume1.23K
Average volume1.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$21.00
52 Week high$21.00
52 Week low$9.60
52 Week low$9.60
Stock Snapshot
As of today, Larkspur Health Acquisition Corp. Unit(LSPRU) shares are valued at $20.80. The company's market cap stands at 168.4M, with a P/E ratio of -102.61.
Larkspur Health Acquisition Corp. Unit(LSPRU) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.
Larkspur Health Acquisition Corp. Unit(LSPRU) shares are trading with a volume of 0, against a daily average of 1.23K.
In the last year, Larkspur Health Acquisition Corp. Unit(LSPRU) shares hit a 52-week high of $21.00 and a 52-week low of $9.60.
In the last year, Larkspur Health Acquisition Corp. Unit(LSPRU) shares hit a 52-week high of $21.00 and a 52-week low of $9.60.